Research article · 18 Feb 2025
Conference abstractPublished 2018
A systematic analysis of physicochemical and ADME properties of kinase inhibitors approved by US FDA prior to 2016
OROX BioSciences, USA Nitto Biopharma Inc., USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In today’s fast-paced and competitive environment, there is an ever-increasing need for more effective and efficient drug design by fully balancing potency, selectivity, molecular properties and appropriate ADME properties early in drug discovery. However, incorporating drug-like properties at the onset is often challenging. Understanding the physicochemical and ADME properties of successful drugs may provide helpful insight in better defining optimization parameters to facilitate this process. We compiled physicochemical and ADME data on kinase inhibitors approved before 2016 and performed a systematic analysis of the common physicochemical and ADME features of these marketed drugs. Although the dataset is limited, valuable conclusions were drawn, which we believe are helpful in selecting helpful assays in a stage-appropriate manner and setting up optimization and advancement criteria during the discovery process. Just as crucial, this work can eliminate unnecessary studies. Details of this work will be presented.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutical Sciences & Emerging Drugs.
Perspective · 23 Aug 2024
Drug Intoxication in Adolescents: Warning Signs and Prevention
Short communication · 20 Aug 2024
Bio-organic Chemistry Approaches to Modulating Protein- Ligand Interactions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Sciences & Emerging Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Mehran F. Moghaddam”
- BylineArticles whose byline prints “Zhihong O’Brien”
